Latest news

Debiopharm Receives cGMP Certification for QC of Drug Products

Debiopharm Life Sciences Award in Neurosciences Goes to Nusser

Clinical update – Debio 9902 (ZT-1) for Alzheimer´s disease

Salvacyl®/ Maopar® 3-month obtains european mutual recognition to treat sexual deviations

Clinical update – Debio 025 cyclophilin inhibitor for the treatment of HCV – A unique viral kinetics

Preclinical update – Debio-0512 therapeutic vaccine for the treatment of chronic and acute inflammatory conditions – Proof of concept in…

Debiopharm signs R&D and Commercialisation Agreement with Kirin for the development of Debio-0719 in Oncology

2006 Mauvernay Research Excellence Award

Debiopharm presents new data confirming anti-HCV activity of cyclophilin inhibitor for Debio-025